{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:40:58Z","timestamp":1791168058204,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,19]]},"DOI":"10.1097\/qad.0b013e3282fd6df4","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T03:05:54Z","timestamp":1212548754000},"page":"1131-1135","source":"Crossref","is-referenced-by-count":168,"title":["Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells"],"prefix":"10.1097","volume":"22","author":[{"given":"Nancy M","family":"Archin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J","family":"Eron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hartmann-Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery A","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bandarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L","family":"Landay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"International AIDS Society-USA Panel. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(06)69152-6","article-title":"Antiretroviral Therapy (ART) Cohort Collaboration. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis","volume":"368","author":"May","year":"2006","journal-title":"Lancet"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.282.17.1627","article-title":"Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy","volume":"282","author":"Dornadula","year":"1999","journal-title":"JAMA"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1128\/JVI.77.3.2271-2275.2003","article-title":"In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months","volume":"77","author":"Di Mascio","year":"2003","journal-title":"J Virol"},{"key":"R6-4-20210130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy","volume":"340","author":"Zhang","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.ppat.0030046","article-title":"ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia","volume":"3","author":"Maldarelli","year":"2007","journal-title":"PLoS Pathog"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/JVI.68.2.905-910.1994","article-title":"Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production","volume":"68","author":"Margolis","year":"1994","journal-title":"J Virol"},{"key":"R12-4-20210130","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1128\/JVI.71.12.9375-9382.1997","article-title":"Repression of HIV-1 through the novel cooperation of the human factors YY1 and LSF","volume":"71","author":"Romerio","year":"1997","journal-title":"J Virol"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1128\/JVI.74.15.6790-6799.2000","article-title":"The human factors YY1 and LSF repress the human immunodeficiency virus type-1 long terminal repeat via recruitment of histone deacetylase 1","volume":"74","author":"Coull","year":"2000","journal-title":"J Virol"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1074\/jbc.M511773200","article-title":"Transcriptional repression of human immunodeficiency virus type 1 by AP-4","volume":"281","author":"Imai","year":"2006","journal-title":"J Biol Chem"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.emboj.7601516","article-title":"Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing","volume":"26","author":"Marban","year":"2007","journal-title":"EMBO J"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.emboj.7600900","article-title":"NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation","volume":"25","author":"Williams","year":"2006","journal-title":"EMBO J"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1128\/MCB.22.9.2965-2973.2002","article-title":"Counter-regulation of chromatin acetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 by the HIV-1 activator tat and the HIV-1 repressor YY1","volume":"22","author":"He","year":"2002","journal-title":"Mol Cell Biol"},{"key":"R18-4-20210130","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/423822","article-title":"Polyamides reveal a role for repression in viral latency within HIV-infected donors' resting CD4+ T cells","volume":"190","author":"Ylisastigui","year":"2004","journal-title":"J Infect Dis"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00002030-200405210-00003","article-title":"Coaxing human immunodeficiency virus type 1 from resting CD4+ T cells: can the reservoir of HIV be purged?","volume":"18","author":"Ylisastigui","year":"2004","journal-title":"AIDS"},{"key":"R20-4-20210130","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.1128\/JVI.76.21.11091-11103.2002","article-title":"Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies","volume":"76","author":"Quivy","year":"2002","journal-title":"J Virol"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","article-title":"Depletion of latent HIV infection in vivo","volume":"36","author":"Lehrman","year":"2005","journal-title":"Lancet"},{"key":"R22-4-20210130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00002030-200005050-00001","article-title":"Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease","volume":"14","author":"Al-Harthi","year":"2000","journal-title":"AIDS"},{"key":"R23-4-20210130","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-6405-3-18","article-title":"IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells","volume":"3","author":"Nomura","year":"2006","journal-title":"AIDS Res Ther"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/JCM.41.10.4531-4536.2003","article-title":"New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma","volume":"41","author":"Palmer","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART","volume":"293","author":"Nettles","year":"2005","journal-title":"JAMA"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/319864","article-title":"Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years","volume":"183","author":"Gunthard","year":"2001","journal-title":"J Infect Dis"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/511823","article-title":"Stability of the latent reservoir for HIV-1 in patients receiving valproic acid","volume":"195","author":"Siliciano","year":"2007","journal-title":"J Infect Dis"},{"key":"R29-4-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QAI.0b013e3180654836","article-title":"Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy","volume":"45","author":"Jones","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-4-20210130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat Biotechnol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200806190-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:03:38Z","timestamp":1786035818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200806190-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,19]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282fd6df4","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,19]]}}}